Gilead Sciences created and sells the world's top-selling HIV medications, Truvada and Atripla, and commands about 75% of the US treatment market and more than. Gilead Sciences · Open. · Previous Close. · High. · Low. · 52 Week High. · 52 Week Low. · Beta. · TTM EPS Trend. (%. Through bold and transformative science, we're driving innovation that has the Stock Information. View current and historic stock prices, analyst. Gilead is traded on the Nasdaq stock exchange under the symbol GILD. back to © Gilead Sciences, Inc. All rights reserved. Powered By Q4. Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed.
Stock price for similar companies or competitors ; Gilead Sciences Logo · Vertex Pharmaceuticals. VRTX. $, % ; Gilead Sciences Logo · AbbVie. ABBV. The latest Gilead Sciences stock prices, stock quotes, news, and GILD history to help you invest and trade smarter. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. What is Gilead Sciences Inc(GILD)'s stock price today? The current price of GILD is $ · When is next earnings date of Gilead Sciences Inc(GILD)?. The next. On Thursday, Gilead Sciences Inc (GILD:NSQ) closed at , % below its week high of , set on Jan 19, week range. Today. May 31 Over the last year, Gilead Sciences, Inc.'s stock price has increased by %. Gilead Sciences, Inc. is currently approximately $ per share. See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions. See charts, data and financials for Gilead Sciences, Inc. GILD. Gilead Sciences, Inc. (sordbiz.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Gilead Sciences, Inc. | Nasdaq: GILD. Gilead Sciences Inc ; Previous Close: ; Volume: 1, ; 3 Month Average Trading Volume: ; Shares Out (Mil): 1, ; Market Cap: 95, Stock Activity ; Open: ; Day Low: ; Day High: ; 52 Wk Low: ; 52 Wk High:
Gilead Sciences | GILDStock Price | Live Quote | Historical Chart ; Neurocrine Biosciences, , , % ; Novartis, , , %. Key Stats · Market CapB · Shares OutB · 10 Day Average VolumeM · Dividend · Dividend Yield% · Beta · YTD % Change The Gilead Sciences Inc stock price today is What Is the Stock Symbol for Gilead Sciences Inc? The stock ticker symbol for Gilead Sciences Inc is GILD. Real-time Price Updates for Gilead Sciences Inc (GILD-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and. Research Gilead Sciences' (Nasdaq:GILD) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. The current price of GILD is USD — it has decreased by −% in the past 24 hours. Watch Gilead Sciences, Inc. stock price performance more closely on. Gilead Sciences Inc. · AT CLOSE PM EDT 08/30/24 · USD · % · Volume6,, Find the latest historical data for Gilead Sciences, Inc. Common Stock (GILD) at sordbiz.ru View historical data in a monthly, bi-annual, or yearly format.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and. Gilead Sciences Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Gilead Sciences (GILD) reported Q2 earnings per share (EPS) of $, beating estimates of $ by %. In the same quarter last year, Gilead. Gilead Sciences (GILD) has a Smart Score of 10 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical.
Analyst Forecast. According to 17 analysts, the average rating for GILD stock is "Buy." The month stock price forecast is $, which is an increase of.